传统疝气修补术与无张力疝气修补术治疗腹股沟疝的疗效对比

摘要/Abstract

摘要： 目的探究传统疝气修补术与无张力疝气修补术治疗腹股沟疝的疗效对比。方法选取2019年1月~2020年12月西安市临潼区中医院收治的76例腹股沟疝患者为研究对象,按照随机数表法将以上患者分成对照组（38例）、研究组（38例）,对照组采用传统疝气修补术治疗,研究组采用无张力疝气修补术治疗,比较两组临床疗效、临床指标、并发症发生率、炎症因子指标。结果治疗后,研究组临床总有效率高于对照组,差异有统计学意义（P<0.05）。研究组术中出血量、手术时间、住院时间及下床活动时间均短于对照组,差异有统计学意义（P<0.05）。治疗前,两组白细胞（WBC）、白细胞介素-6（IL-6）、C反应蛋白（CRP）炎症因子指标比较,差异无统计学意义（P>0.05）;治疗后,研究组WBC、IL-6、CRP水平均低于对照组,差异有统计学意义（P<0.05）。研究组切口感染、尿潴留及阴囊水肿的并发症发生率均低于对照组,差异有统计学意义（P<0.05）。结论对腹股沟疝患者实施无张力疝气修补术疗效优于传统疝气修补术,可抑制炎症反应、降低并发症发生率、缩短住院时间。

关键词: 传统疝气修补术, 无张力疝气修补术, 腹股沟疝

Abstract: Objective To compare the outcome of traditional hernia repair with tension-free hernia repair in the treatment of inguinal hernia. Methods 76 patients with inguinal hernia in Xi'an Lintong Hospital of Traditional Chinese Medicine from January 2019 to December 2020 were involved in present investigation.The patients were randomly divided into control group (38 patients) and research group (38 patients).The patients in control group were subject to traditional hernia repair while the patients in research group received tension-free hernia repair.The clinical outcome,clinical indicators,incidence of complications,and proinflammatory cytokines among the two groups were compared. Results After treatment,clinical outcome in research group was significantly better than control group (P<0.05). Intraoperative blood soss,operation time,length of stay,and postoperative activity time in research group were less than control group with the statistical significance (P<0.05).Before treatment there were no significant differences for white blood cells (WBC),interleukin-6 (IL-6) and C-reactive protein (CPR) between research group and control group (P>0.05).However,after the treatment,WBC,IL-6 and CPR in research group were remarkably reduced compared to control group,which showed statistical significance (P<0.05).Meanwhile,the incidence of complications encompassing incision infection, uroschesis and scrotal edema in research group was much lower than control group (P<0.05). Conclusion Tension-free hernia repair is better than traditional hernia repair for the treatment of inguinal hernia, which could inhibit inflammation,reduce the incidence of complications,and shorten the length of stay.

Key words: traditional hernia repair, tension-free hernia repair, inguinal hernia

中图分类号:

R657.8

牛卫. 传统疝气修补术与无张力疝气修补术治疗腹股沟疝的疗效对比[J]. 中华养生保健, 2022, 40(11): 20-23.

NIU Wei. Outcome of Tension-free Hernia Repair Compared with Traditional Hernia Repair in the Treatment of Inguinal Hernia[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(11): 20-23.

参考文献

[1] 王步云,雷磊.疝气无张力修补术治疗老年腹股沟疝患者的效果[J].实用临床医药杂志,2020,24(8):104-106.
[2] 吴振阳. 无张力疝修补术在老年腹股沟疝治疗中的应用及价值研究[J].中国现代药物应用,2020,14(4):73-75.
[3] 高超,闫治波,王明刚,等.压迫治疗对单侧腹股沟疝无张力修补术后发生血清肿影响的倾向评分匹配分析[J].中华消化外科杂志,2020,19(7):742-750.
[4] Karatepe O, Adas G,Battal M,et al.The comparison of preperitoneal and lichtenstein repair for incarcerated groin hernias: a randomised controlled trial[J].Int J Surg, 2008,6(3):189-192.
[5] 中华医学会外科学分会疝与腹壁外科学组,中国医师协会外科医师分会疝和腹壁外科医师委员会.成人腹股沟疝诊断和治疗指南(2018年版)[J].中华外科杂志,2018,56(7):495-498.
[6] 王安朋,李新力,邸军.腹股沟疝气充填式无张力与平片无张力疝修补手术治疗效果对比[J].黑龙江医学,2019,44(9):1002-1003.
[7] 傅厚丰,符敏,杨河,等.腹腔镜下经腹腹膜前疝无张力修补术与传统术式治疗腹股沟疝患者近期效果比较[J].中国医药,2019,14(12): 1851-1853.
[8] 雷延伟,樊广业,吕应索.腹腔镜疝气修补术与腹膜前间隙无张力疝修补术治疗腹股沟疝患者的疗效[J].医疗装备,2018,31(21):131-132.
[9] 陈志福. 疝气无张力修补术在老年腹股沟疝气治疗中的应用效果分析[J].现代诊断与治疗,2018,29(1):4-5.
[10] 姚良本. 无张力疝气修补术与传统疝气修补术治疗腹股沟疝对比性研究[J].现代诊断与治疗,2018,29(9):1464-1465.
[11] 徐进. 开放式完全腹膜外疝修补术与传统无张力疝修补术治疗老年腹股沟疝比较[J].中国老年学杂志,2019,39(22):5524-5527.
[12] 刘波. 腹膜外腹腔镜疝气修补术与传统疝修补术治疗腹股沟疝的疗效对比[J].昆明医科大学学报,2020,41(4):127-131.
[13] 周辛欣. 不同方式无张力疝修补术治疗腹股沟疝气的疗效对比分析[J].现代诊断与治疗,2018,29(12):1932-1934.
[14] 陈晓博. 有张力、无张力修补术治疗腹股沟疝气患者的临床效果对比[J].医药论坛杂志,2018,39(1):114-115.
[15] 许泽锋. 不同手术治疗方式治疗100例腹股沟疝气患者的临床效果对比[J].当代医学,2018,24(33):154-156.
[16] 曹亮,王步云.对比分析开放式无张力疝修补术与腹腔镜疝修补术治疗成人腹股沟疝的临床疗效[J].贵州医药,2020,44(3):410-412.
[17] 王克诚,徐樊,姜飚.传统开放式修补术与腹腔镜无张力修补术治疗腹股沟疝的临床应用对比分析[J].解放军医药杂志,2020,32(8):66-69.
[18] 肖康. 无张力疝气修补术和传统腹股沟疝修补术治疗腹股沟疝的效果及复发率分析[J].中国实用医药,2018,13(8):27-29.
[19] 郑念刚. 传统疝气修补术与无张力疝气修补术治疗腹股沟疝的效果及安全性观察[J].中国实用医药,2019,14(7):34-35.